Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 45.09
H 46.38
L 43.93
C 44.44
V 1,749,564
10EMA 44.44
20EMA 44.44
60EMA 44.44
120EMA 44.44
250EMA 44.44